Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2025-12-30 @ 3:53 PM
Study NCT ID:
NCT03793361
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2018-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Regorafenib as Maintenance Therapy
Sponsor:
Centre Oscar Lambret
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-28
First Submit QC Date:
None
Study First Post Date:
2019-01-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-09
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL